Literature DB >> 22884044

Awareness of secondary stroke prevention guidelines among neurologists in China: a cross-sectional online survey.

Jian Wu1, Long-Fei Jia, Jian-Ping Jia.   

Abstract

BACKGROUND: Recurrent stroke following a transient ischemic attack or minor stroke is frequent but potentially preventable. The prevention outcome is, by and large, dependent on how well physicians understand and implement prevention guidelines. Yet, little is known about the scope of physicians' awareness and implementation of secondary stroke prevention guidelines in the mainland of China. This study aimed to identify the gaps between physicians' clinical practice and guidelines for secondary stroke prevention in China.
METHODS: A nation-wide online survey with a 16-item questionnaire that reflects major components of the Chinese National Secondary Stroke Prevention Guidelines was performed between September 1, 2009 and October 31, 2009.
RESULTS: A total of 3489 neurologists from third tier hospitals completed the survey. The percentage of the physicians who were aware of the control targets and prevention measures recommended in the Chinese national guidelines was generally lower than reported for developed countries.
CONCLUSIONS: Physicians in the mainland of China lack sufficient awareness of secondary stroke prevention guidelines. Continuing education is highly recommended.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884044

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Low awareness of stroke guidelines and preference for Chinese herbs in community physicians: a national survey in China.

Authors:  Jing-Wen Niu; Jing Yuan; Shan Gao; Wei-Hai Xu
Journal:  Ann Transl Med       Date:  2014-08

2.  Community physicians' knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China.

Authors:  Chen Chen; Xiaoyuan Qiao; Huijie Kang; Ling Ding; Lixia Bai; Jintao Wang
Journal:  BMC Med Educ       Date:  2015-11-03       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.